Literature DB >> 7094501

Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

B Dahlström, A Tamsen, L Paalzow, P Hartvig.   

Abstract

The influence of anaesthesia and surgery on the pharmacokinetics of morphine was studied in 10 patients. Plasma concentrations of morphine were assayed by gas chromatography with electron capture detection. All patients were studied on the day of surgery and again 3 to 7 days later. Mean +/- SD for peroperative Vd(area) was 6.3 +/- 3.6 L/kg and for the terminal half-life was 3.8 +/- 2.3 h. In the postoperative period, Vd(area) decreased to 3.7 +/- 1.4L/kg and the terminal half-life to 2.2 +/- 1.1 h. Plasma clearance (Clp) remained constant, peroperative Clp being 20 +/- 7.0 ml/min/kg and postoperative Clp 21 +/- 6.0 ml/min/kg. Postoperative pain was relieved by patient-controlled administration of intravenous doses of morphine by means of a programmable drug injector. The mean morphine consumption was 2.6 +/- 1.2 mg/h, which produced a mean plasma concentration of 21 +/- 12 ng/ml with a calculated mean minimum effective concentration (MEC) of 16 +/- 9 ng/ml. In 1 patient, temporary hypercapnia was seen during a period of hypovolaemia. Analgesia was considered satisfactory by all patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094501     DOI: 10.2165/00003088-198207030-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  26 in total

1.  Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents.

Authors:  G T Tucker; L E Mather
Journal:  Br J Anaesth       Date:  1975-02       Impact factor: 9.166

2.  The optimal dose of morphine.

Authors:  L LASAGNA; H K BEECHER
Journal:  J Am Med Assoc       Date:  1954-09-18

3.  Quantitative determination of morphine in biological samples by gas-liquid chromatography and electron-capture detection.

Authors:  B Dahlström; L Paalzow
Journal:  J Pharm Pharmacol       Date:  1975-03       Impact factor: 3.765

4.  The diposi tion of morphine in surgical patients.

Authors:  B A Berkowitz; S H Ngai; J C Yang; J Hempstead; S Spector
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

5.  Pharmacokinetics of morphine: effects of hypercarbia on serum and brain morphine concentrations in the dog.

Authors:  A D Finck; B A Berkowitz; J Hempstead; S H Ngai
Journal:  Anesthesiology       Date:  1977-11       Impact factor: 7.892

6.  Quantitative determination of morphine in serum by radioimmunoassay.

Authors:  S Spector
Journal:  J Pharmacol Exp Ther       Date:  1971-08       Impact factor: 4.030

7.  Disposition of morphine in man.

Authors:  S Spector; E S Vesell
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

8.  Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

9.  Pharmacokinetics of morphine by radioimmunoassay: the influence of immunochemical factors.

Authors:  D H Catlin
Journal:  J Pharmacol Exp Ther       Date:  1977-01       Impact factor: 4.030

10.  Morphine kinetics in children.

Authors:  B Dahlström; P Bolme; H Feychting; G Noack; L Paalzow
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

View more
  46 in total

1.  Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue.

Authors:  A J Lawrence; G P Joshi; A Michalkiewicz; W P Blunnie; D C Moriarty
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  A computer-based system for controlling plasma opioid concentration according to patient need for analgesia.

Authors:  H F Hill; R C Jacobson; B A Coda; A M Mackie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

Review 3.  Pharmacokinetic optimisation of opioid treatment in acute pain therapy.

Authors:  R N Upton; T J Semple; P E Macintyre
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

4.  Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations.

Authors:  J Hasselström; N Alexander; C Bringel; J O Svensson; J Säwe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Absence of morphine glucuronidation in the human lung.

Authors:  F M Ratcliffe
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

7.  Patient-controlled analgesia with nalbuphine, a new narcotic agonist-antagonist, for the treatment of postoperative pain.

Authors:  K A Lehmann; B Tenbuhs
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

9.  Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

10.  Morphine kinetics after diamorphine infusion in premature neonates.

Authors:  D A Barrett; A C Elias-Jones; N Rutter; P N Shaw; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.